Prior Auth Required

81270 - JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServiceJAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe
Procedure / Service Description

cultures, or additional zygosity in multiple birth pregnancies) (List separately in - 81269 HBA1/HBA2 (alpha globin 1 and alpha globin 2) (eg, alpha thalassemia, Hb Bart hydrops fetalis syndrome, HbH disease), gene analysis; duplication/deletion variants 81270 JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, p.Val617Phe (V617F) variant 81271 HTT (huntingtin) (eg, Huntington disease) gene analysis; evaluation to detect

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.